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Abstract
Background: Tuberculosis remains an important disease which mainly affects the majority of vulnerable individuals
in society, who are subjected to poor living conditions and difficulties to access the services of public health. Under
these circumstances, the present study aims to understand patients’ perception in relation to the influence of
individual and social vulnerabilities on the adherence to tuberculosis treatment.
Methods: A qualitative descriptive cross sectional study was conducted in one large municipality at the state of
Paraíba, Northeast of Brazil. The study subjects, who were residents of the study site, covered all tuberculosis cases
diagnosed between March and June 2015. The sample was defined by the criteria of response saturation. All
interviews were audio recorded, and data analysis was developed through the hermeneutic dialectic method and
the theory of Generative Route Sense. The project was approved by the Research Ethics Committee of the
University of São Paulo (USP).
Results: A total of 13 individuals were interviewed and the responses were identified into two analytical categories:
the difficulties they had and the enabling factors they could mention during their tuberculosis treatment. Patients
brought up social exclusion as an obstacle to treatment adherence, which, along with stigmatization, weakened their
link with family members and health professionals. Moreover, economic precariousness was a major hindrance to the
maintenance of a proper diet and transportation access to health centers. However, social support and directly
observed treatment helped to break down barriers of prejudice and to promote individual and family empowerment.
Finally, patients also reported that their will to live and faith gave them the strength to continue with the treatment.
Conclusions: According to patients in this study, social support and the strengthening of links with family members
and health professionals may reduce social exclusion and other difficulties they face, thus encouraging them to the
adhere to tuberculosis treatment.
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Background
Tuberculosis (TB) remains as one of the major global in-
fectious diseases. It is estimated that one third of the
world’s population is infected by the Mycobacterium
tuberculosis and that 10, 4 million individuals were
affected by the disease in 2015 [1].
The World Health Organization prioritized a list of 30
countries that concentrate 87.1% of the total global bur-
den of TB cases [1]. According to international ranking
indicators, Brazil takes the 20th position on this list. In
fact, a total of 63.189 cases of the disease were reported
in the country in 2015, including pulmonary and extra-
pulmonary forms, which corresponds to an incidence of
33 cases per 100.000 population. In the state of Paraíba,
1.525 cases of TB were registered, with an incidence rate
of 40.5 cases per 100,000 in habitants [2] and 79 death
cases [3].
The WHO established the following goals for the con-
trol of the disease for the year 2015: to halt and reverse
TB incidence coefficient according to what was pro-
posed by the Millennium Development Goals, and to re-
duce prevalence and mortality indicators by 50% in
relation to the 90s according to the Stop TB Partnership
strategy [4]. Brazil achieved the goals related to inci-
dence, prevalence and mortality [5]. However, cure and
loss to follow-up rates are still below those proposed by
the WHO and agreed by the National TB Control
Program, which are to cure at least 85% of the cases and
to reduce loss to follow up to levels below 5% [1, 6]. In
the year 2014, 75.1% of the patients were cured and
11.3% individuals were lost to follow up in the country.
In the state of Paraíba, the cure and loss to follow-up
rates were respectively 65.5% and 11.8% [2]. This is an
alarming situation since the low cure and the high loss
to follow-up rates can lead to an increase in the TB
incidence and mortality levels all over the country [7].
In this context, treatment adherence plays a central
role in the disease control given the fact the treatment
favors improvement in the indicators of loss to follow up
and cure [8]. Nevertheless, disease control remains as a
challenge for global public policies; treatment adherence
is a multicausal process that transcends biological, clin-
ical or behavioral aspects, and it is associated with the
way patients conceive the disease, their social condition
that should allow for the development of life with dig-
nity, and the support from health services. Adherence is,
in fact, influenced by the social determinants of the
health-disease process [9].
Many are the barriers that increase vulnerability and
the risk for treatment non-adherence. Among these bar-
riers are the long duration of treatment, drug intolerance
associated with clinical improvement at the initial
months of treatment [8], low socioeconomic and school
level, lack of knowledge about the disease, lack of social
incentives, homeless living situations, alcoholism and
illicit drug use [10, 11], social and individual stigma and
lack of support from family members and health profes-
sionals [12–14].
There is a predominance of the disease among male pa-
tients in the economically active age group. This group is
considered vulnerable to treatment loss to follow-up [15]
since many times patients’ working hours and health ser-
vices opening hours are incompatible, thus making the ac-
cess to such services very difficult [16]. Additionally, the
reduction of work capacity due to the disease itself and
the adverse effects of the antituberculosis drugs [8, 12]
contributes to treatment non-adherence.
Treatment non-adherence contributes to higher rates
of treatment loss to follow-up and multidrug resistance
[1]. These are factors that hinder the cure process, bring
suffering and cause economic losses not only to the pa-
tient, who is frequently laid off from work, but also to
the state budget since the treatment becomes more
costly [8, 17].
Therefore, whenever socioeconomic diseases like TB
are studied, treatment adherence must be studied under
the light of vulnerability [18]. In a broader sense, vulner-
ability reflects the potential for getting sick, for not get-
ting sick and for coping with the health-disease process
resultant from the interconnected and inseparable indi-
vidual, social and programmatic aspects. The potential
for getting sick reflects the social inequity that affects
the general population, which, in turn, stimulates (or
not) the adherence to treatment [19].
The individual vulnerability is determined by cognitive
conditions inherent to the access to the information on
the health-disease process and the capacity to elaborate
and put this information into practice on a daily basis.
In this context, the individual holds certain rights that
must be protected by the social aspect insofar as the so-
ciopolitical, economic and cultural context can favor the
access to social resources, paramount to the mainten-
ance of health, and the adoption of social protection
measures. Such measures should be reinforced by the
programmatic plan that is based on the political and
institutional commitment to the funding, operationaliza-
tion and evaluation of public programs and policies for
disease prevention as well as health promotion and
assistance [19, 20].
Hence, in order to identify the vulnerabilities in the
process of treatment adherence and establish a strategy
for effective interventions, not only individual elements
(behavioral and clinical) should be taken into consider-
ation but also the relation of the subjects to their social
contexts, their life conditions and accessibility to the
available disease control programs and services [19].
Such aspects are strongly related to the individual, social
and programmatic vulnerabilities.
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Although the three aspects of vulnerability are insepar-
able, Ayres, Paiva, França et al. [20] state that for a dee-
per understanding of vulnerability, it must be considered
that the social environment plays an important role in
individual behavior, and in this dimension, relations be-
tween people and the world are established [21]. There-
fore, it is important to keep these factors of individual
and social vulnerability in perspective, in order to iden-
tify the potentialities and fragilities in patients in their
fight against the disease, so that strategies that favor
their adherence to treatment can be strengthened and
the loss to follow-up rate can be reduced.
The present study aim to understand patients’ percep-
tion in relation to the influence of individual and social
vulnerabilities on the adherence to tuberculosis treat-
ment. As a result, it may shed some light on the import-
ance of the operationalization of intersectoral and social
assistance actions that will help managers, health author-
ity and society to see the individual as a whole in the
social environment.
Methods
Study setting
The location adopted for this study was the municipality
of Campina Grande, (Fig. 1), located in the mesoregion
of Agreste Paraibano, Northeast of Brazil. Considered
the second largest municipality in the state of Paraiba in
terms of territorial extension (407.754 km2), population
level (593.026 inhabitants) and economic importance.
The human development index (HDI) in the municipal-
ity is of 0.720 [22].
The municipality has an important university center and
attracts students from other states of Brazil, which con-
tributes to the increase of the local economy. The main
economic activities developed in the municipality include
agriculture, livestock, mineral extraction, handicrafts,
trade. It also stands out in the production of software for
export, and for this reason is considered one of the main
industrial hub of the Northeast Region and the largest
technological hub of Latin America. It has the second lar-
gest GDP in the state, accounting for 15.63% of the total
wealth produced in Paraíba [22].
In relation to health sector, the municipality has a struc-
tured network of health services which is a reference for
other municipalities in Paraíba and Brazilian states.
According to the state’s geopolitical administrative div-
ision, the municipality is home to the third Regional
Health Center covering 70 municipalities of the state [23].
The municipality was chosen for this study because it
concentrates the second largest tuberculosis burden in
the state, and is considered a priority by the National
Tuberculosis Control Program, TB control actions are
developed by 94 family health teams, distributed in 88
Basic Health Units [24], by one Secondary Outpatient
Clinic in TB, with support from the tertiary level by the
municipal hospitals and the Clementino Fraga Hospital,
a reference related to patients with infectious diseases,
located in the capital of State (João Pessoa) 130 km away
from the municipality.
Study design
This is a multicentric, qualitative, descriptive, cross-
sectional study that evaluated the effectiveness of so-
cial protection measures towards the improvement of
programmatic indicators for TB treatment adherence
and control of the disease in some regions of Brazil.
The studied population comprised all cases of tuber-
culosis diagnosed between March and June, 2015, to-
taling 45 patients. The screening process included
under-treatment patients aged 18 years or older, who
were capable of understanding and answering
questions, and lived in the area where the study was
Fig. 1 Brazil, Northeast region, state of Paraiba and municipality of Campina Grande
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conducted. Prison inmates or hospitalized patients
were excluded, remaining 20 individuals to be
contacted.
For the definitive composition of the sample, it was re-
quested the database of the National System of Notifi-
able Diseases of the Municipal Health Department of
the municipality studied, from which a list with the
name, telephone number and address of the patients
was extracted, then the subjects were contacted in a
simple random manner, by randomness and interviewed
according to their availability. The sample was defined
based on the saturation of the information contained in
the statements.
Data were collected in August 2015, at the place of
choice of the patients, domicile or health service,
through an interview with a semi-structured script. The
initial questions gathered data about the characterization
of the subjects: sex, age, level of schooling and clinical
form of tuberculosis. The following steps were questions
like: What difficulties and facilities did you have during
the tuberculosis treatment? Depending on the subject’s
responses, the researcher formulated new questions for
monitoring, allowing a deeper understanding of the sub-
ject and observing the individual perceptions of tubercu-
losis treatment, allowing the participants to guide the
discussion.
Researchers were coached on the conduction of the
interview prior to data collection. The interview lasted
around 20 min, and the statements were audio recorded
and fully transcribed1 doubly by two researchers, by isola-
tion form, on a Microsoft Word 2010 document. The
studied subjects were then identified by the letter I, which
stands for the word interviewee, and numbered according
to the order of the interview (I1, I2, I3, and so on).
The responses were analyzed in pairs and then were
interpreted the light of dialectical hermeneutics [25] and
the theory of Generative Route Sense [26]. The integra-
tion of the two analysis techniques aims to achieve a
broader complementarity so that a more realistic view of
the studied context could be assessed; thus, the know-
ledge, interpretation and reinterpretation [27] of the pa-
tient’s history in the process of adhering to the TB
treatment within a social background can be better
understood.
Hermeneutics deals with the analysis of texts, state-
ments and narratives. Its interpretation is not detached
from praxis, and it is intrinsically related to intersubject-
ivity, namely the ability to put oneself in someone else’s
place. It takes the individual’s discourse into consider-
ation within the historical and totalizing specificity in
which it is produced. Dialectic tries to discuss contra-
dictory facts in language, signs and culture; the dialect-
ical process suggests that the interpretative analysis
should emphasize social phenomena according to the
dynamicity they occur. The connection of these concepts
allows for the comprehension of how facts express
themselves and occur from the interaction between indi-
viduals and the understanding of the reality expressed in
the discourse [25].
The theory of Generative Route Sense is based on the
understanding that language and discourse cannot be
dissociated from the individual’s view of the world in
accordance with life conditions and social relations.
Therefore, the discourse reveals the reality and enables
the understanding of the text by the identification of
figures that are expressed by words or concrete expres-
sions. When interrelated, they form a figurative pathway;
the sense of this narrative set is represented by a central
theme of the discourse related to abstract elements that
organize and categorize the senses as well as the articu-
lation between figures and themes. As a result, the
restructuring of the discourses into theme sentences
occur, reflecting the perception of individuals as to the
objective of the study [26].
Human ethics approval
The study was approved by the Research Ethics Commit-
tee from the School of Nursing at the University of São
Paulo (USP) under the number 37254714.0.1001.5392.
Results and discussion
The characteristics of the 13 interviewed patients are
shown in Table 1. There was a prevalence of males
(76.9%) between 21 and 35 years of age (59.9%), with 4
to 7 years of schooling (46.2%) and pulmonary form of
TB (92.3%).
After the statements were analyzed, they were divided
into two analytical categories: the difficulties they had
and the enabling factors they could mention during their
tuberculosis treatment, based on individual and social
vulnerability elements.
Category 1: Difficulties met during the treatment.
According to the participants, “Many were the difficul-
ties” (I1, I2, I4, I5, I11, I12, I13) to be overcome during
the treatment. The first obstacles were “prejudice” (I5,
I11 and I13) and social discrimination: “(…) you are con-
demned for having the disease” (I12), especially by family
members and friends; “I’ve been very criticized, extremely
judged (…). People didn’t want to help me in any way.”
(I13).
As can be noted, TB still carries stigmas and preju-
dices that are harmful to the “TB guy” (I12). The suffer-
ing the disease brings is worsened with the segregation
and social isolation. For patients, the idea of sharing the
diagnosis with family and friends resided in the fact that
they needed to find the strength to fight the disease;
however, some were caught by surprise when they
started being avoided by those people around them,
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which reinforces the prejudicial perception and makes
the individual vulnerable to the non-adhesion to
treatment.
In fear of this kind of reaction, some patients decide to
“hide the disease” (I12, I11) as a strategy to keep a social
life. Not revealing the diagnosis is thus a solution they
find to avoid rejection and shame as well as an obstacle
to treatment at the same time: “It’s tough for the guy to
explain (...) it’s embarrassing (...)” (I11). Furthermore,
patients’ self-stigmatization regarding the perception of
the disease supported by ideologies and current social
values may trigger an existential crisis and a low self-
esteem process: “How would people see me? As a TB guy
or as a human being?” (I12).
Therefore, the negative attributions to TB patients
make acceptance and control of the disease difficult.
Patients feel unmotivated to undergo the treatment and
the evaluation of TB contacts by health professionals is
hindered, causing a delay in the detection of latent and
active TB cases [28].
According to Lacerda et al. [17], social stigma comes
from the general population’s lack of knowledge on TB.
Thus, health education plays an important role in the
explanation of the disease and treatment to patients and
family members, allowing for the deconstruction of stig-
mas and prejudices [29]. It is essential that health pro-
fessionals see beyond the biomedical model, which
focuses on the disease and the individual, and have a
more intersubjective, dialogical approach so that patients
with their knowledge can be taken into consideration. In
such case, the aim is not only to inform patients about
the shades of the health-disease process but also to
change their concepts through the development of
health awareness [30, 31].
In result, directly observed treatment (DOT) is an
indispensible tool for the therapy, once it aims to moni-
tor the medication intake and strengthen the bond of
health professionals with patients and family members.
DOT brings them closer to health services and provides
full assistance in biological and psychosocial terms,
which allows for the previous detection of vulnerability
aspects that may interfere with treatment adherence
[32]. Therefore, it is of utmost importance that health
professionals pay careful heed to patients’ needs.
All the care and support supplied to patients by health
services help to strengthen the bond and the co-
responsibility in the treatment process [27]. On the
other hand, a weak link tends to cripple the cure
process: “The doctor is a pain in the neck; she doesn’t
treat us right; she is very rude” (I5). Such situation raises
vulnerability issues regarding the non-adherence to
treatment given the fact the patient feels unmotivated to
search for assistance in health centers.
According to the statements, it was possible to infer
that patients perceived the lack of social support and the
self-administered treatment model as barriers to start
therapy, especially when they had other comorbidities
like depression, for example: “As I suffer from depression
(...) sometimes I forget to take the medicine (...) then it
starts all over again” (I13). Vulnerability to the non-
adherence is again increased since the patient feels dis-
couraged to face the disease alone, particularly when
drug interactions and the adverse effects of the antitu-
berculosis drugs occur [32, 33].
As for antituberculosis drugs, patients stated that “the
medication is strong” (I4), “tastes awful, especially in the
first months of treatment” (I2), when they are more de-
bilitated and the medication is more powerful (Coxcip-
42), with adverse effects that directly interfere with their
daily habits: “It's hell really; it feels like I’m gonna faint,
and sometimes I don’t sleep at night” (I1). This situation,
along with specific symptoms of the disease - “pain in
the lungs” (I5), “the person gets tired and sweats a lot”
(I11) - directly impose limitations to patients in their
labor activities (I5, I6, I13). Medical leaves of absence
are frequent – “I stopped working for 3 months ‘cause I
couldn’t be exposed to the cold weather. Since I work at
night, things got messed up,” (I3) - and even by un-
employment too (I1, I4, I11, I12).
The situation is aggravated when the patient is a male
within the economically active age group, which is the
prevailing profile of this study. Historically, these men are
Table 1 Overall characteristics of the studied patients
Characterization of the Studied Individuals
No %
Sex Male 10 76.9
Female 3 23.1
Age Group 21–25 3 23.1
26–30 1 7.7
31–35 3 23.1
36–40 1 7.7
41–45 0 ─
46–50 2 15,3
51–55 1 7.7
56–60 0 ─
>60 2 15.3
Educational Level Unschooled 1 7.7
1–3 years 2 15.3
4–7 years 6 46.2
8–11 years 3 23.1
>12 years 1 7.7
Clinical Form Pulmonary 12 92,3
Extra-pulmonary 1 7,7
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in charge of providing financial support to their families;
thus, incapacity for work results in socioeconomic losses
not only for patients, but also for their dependents. In the
very first months, the false sensation of health recovery,
associated with the discomfort caused by the adverse
effects of the drugs, lead these patients to treatment non-
adherence due to the urge to go back to work.
Work incapacity negatively interferes with the family
budget. Many patients could not afford “the well-balance
diet” (I4, I5, I6, I12, I13) required by the treatment:
“Food that we didn’t have” (I1), “One day I barely had
something to eat” (I4), “If only I had some juice to take
the medicine (...), but i’s hard to swallow it down with
water because it tastes like kerosene.” (I6).
Besides weakening the immune system and affecting
patients’ clinical evolution [34], malnutrition causes
enhanced adverse effects like nausea, weakness and
abdominal pain [35]. It is clear that adverse effects and
the economic situation form a vicious cycle, in which
one condition may trigger the other.
Poor living conditions make accessibility to health
services even more difficult when health centers are
far from the patient’s residence. In such cases, the
bond between health professionals and patients is
affected (I1, I4, I5, I12), and treatment costs become
significantly higher when transportation expenses are
added to the family budget, especially in the face of the
“current economic crisis the country has been going
through,” (I5) and the lack of community support and
social incentives: “You are a structure without any
financial support; you have nothing.” (I12).
The fact that patients who live far from health centers
have to commute to undergo the DOT may be a hin-
drance to treatment continuity, either due to the lack of
financial support or the time spent on transportation
[36]. According to Luna et al. [16], long distances also
weaken the execution of programmatic strategies, like
home visits by health professionals. However, other stud-
ies reveal that in some situations the farther the services
are from home, the easier it is for the patient to adhere
to the treatment. In other words, the health center is
seen as a haven from exclusion and neighborhood dis-
crimination [11, 37]. In this study, some patients also
mentioned the distance as a convenience, namely a form
of protection against prejudice.
Such finding shows that no matter how near or
how far patients live from health services, their per-
ceptions regarding this distance vary from difficult to
convenient according to the social context they are
in. It is implied then that the decentralization of TB
control actions to the primary care level will only be
successful when society overcomes the stigma of the
disease and understands that the cooperation from all
citizens is essential for TB control. Nevertheless,
while the desired outcome is not achieved, in-home
DOT expansion strategies should be designed and fi-
nancial support for transportation to and from health
services should be provided. These temporary solu-
tions would help not only to strengthen adherence to
treatment but also to reduce social exclusion.
In the literature, the distribution of incentives
(“baskets” of basic food staples, snacks, transportation
vouchers and disability benefits) have proven to be very
important for the continuation of treatment and the
reduction of social exclusion [33], so such incentives
should be provided to patients during the therapeutic
period. However, it was observed that most of the
patients under treatment did not receive any kind of
food or financial support, probably because of the lack
of funds of the PNCT from the studied municipality.
Consequently, patients feel discouraged to adhere to the
treatment, especially those who are more economically
disadvantaged.
In a study conducted in Argentina, the authors reveal
that patients undergoing financial hardship who had to
pay for transportation costs to and from health services
were approximately three times more likely to abandon
the treatment than those who received transportation
vouchers [36]. In Brazil, many studies show that incen-
tives like food and financial support strengthen treat-
ment adherence [11, 37].
Alcoholism was also mentioned as a barrier to treat-
ment adherence: “I ended up drinking, and I knew that I
couldn’t drink alcohol under treatment, so I didn't take
the medicine” (I9). It is known that chronic alcoholism
makes patients susceptible to malnutrition and immuno-
depression, which delay the cure process and intensify
adverse reactions [17, 38]. Moreover, this group suffers
from social exclusion and emotional disorders, including
lack of family support [39], which interfere with the
disease acceptance and put patients in a situation of
vulnerability to treatment non-adherence.
Category 2: Enabling factors during TB treatment.
According to patients, the distribution of antitubercu-
losis drugs by the Public Health Network helps adher-
ence, but by itself it is not enough for treatment
continuity. First of all, therapeutic adherence is boosted
by the will of living and the desire to be healed, particu-
larly when patients are motivated to develop life projects
and they are bound by ties of affection.
Achieving success in TB treatment becomes easier
when patients keep social relations flowing and do not
suffer from the stigma. Interviewees reported that sup-
port from “family members” (I5, I8, I10, I11) and “some
friends” (I1) “motivated them to move on” (I11) and
“continue with the treatment” (I5, I8, I10, I11). Further-
more, this support helped them accept the disease and
overcome obstacles.
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The family represents the social group closest to pa-
tients, whose support is fundamental to treatment ad-
herence. Therefore, health professionals can not only
provide a more qualified assistance targeting patients’
needs but also develop health educational actions on in-
dividual and family empowerment once they know the
family dynamics [40].
According to the perception of patients, health profes-
sionals’ support was also fundamental to treatment con-
tinuity (I1, I11, I13): “The doctor told me to continue
with the treatment so that I could heal” (I11); “Once I
made up my mind to stop taking the medicine; then the
nurse came, insisted (...). I spent two weeks without tak-
ing the medicine, and after the nurse and the social as-
sistant strongly insisted, I started taking it again.” (I13).
In this context, the strengthened bond helped establish
a trust relationship, based on dialogue and respect, be-
tween patients, family members and health professionals,
which favored the understanding of the importance of
the treatment and its correct application [15].
DOT has proven to be a valuable tool for adherence
once it gives health professionals a better understanding
of patients’ perceptions on the fight against the disease
in relation to the social context they are in. As a result, a
broader and more qualified assistance can be provided
to patients according to their needs, as seen in other
studies [16, 29]: “It’s good (...) The orderlies come and
clearly explain everything to me.” (I8).
The proximity of patients’ residences to health services
was also a determining factor for treatment continuity
and DOT performance: “Because the health center is
very close to my house, I don’t have to pay for transporta-
tion. But if I had to go every day (...) and pay the bus fare
to take the medicine, then it would be expensive” (I9).
This situation can compensate the lack of social incen-
tives and the low-income situation of local patients [41].
Faith and religiosity also took on an important role in
treatment continuity. Patients feel strong enough to cope
with all the difficulties imposed by the disease, and they
believe that in the hope of “feeling better” (I7), their recov-
ery occurs through intervention of the divine. The energy
acquired though faith leverages their cure desire, and sub-
stantially contributes to treatment adherence [8, 11] and
the return to daily activities like work [33].
Upon analyzing the responses regarding the enabling
factors and difficulties in the disease treatment, it was pos-
sible to observe that patients perceive social exclusion as
the greatest difficulty for treatment adherence. This exclu-
sion is sometimes intensified by stigmatization/auto-
stigmatization, segregation/social isolation, financial issues
or lack of social protection incentives, or eased by the
strengthening of the bond with family members and
health professionals. Moreover, according to patients, faith
and religiosity, when linked to the will to live, positively
influenced on the decision to continue with the treatment
and be cured.
The study also revealed the urgency of combating
stigma, which may perhaps be obtained through Health
education strategies that highlight the patient-family en-
gagement, and target the individual and collective em-
powerment regarding the deconstruction of prejudices,
the strengthening of interpersonal bonds and a greater
political awareness in the fight for health rights. The dir-
ectly observed treatment (DOT) program also needs to
be expanded, and social protection strategies, like food
and financial support, must be improved so that the so-
cial exclusion issue is minimized.
As possible limitations of the study, the punctual
period of data collection can be pointed out, in which
resulted in a reduced sample size and whose discourses
may have suffered interference from the historical, polit-
ical and temporal context in the study site.
Conclusions
The difficulties and enabling factors reported by the TB
patients reinforce the view that only the availability and
free distribution of the medication is not enough for
treatment continuity or the cure. There are social and
individual vulnerability aspects that may hinder or
strengthen this process. These findings were also
highlighted in other cultural realities distributed in other
regions and countries of the world, based on literature
review, which brings about new insights and under-
standing about the health of the population.
Therefore, it is noticeable that the TB issue involves
multiple conditioning factors. Its control is complex due
to the fact it demands reciprocal moral and ethical com-
mitment from the whole society to patients, who, as so-
cial actors, must struggle for dignified life conditions.
The epidemiological control of the disease is broad,
and it has to go through barriers from political govern-
ment agencies. It is questionable whether global efforts
for the control of the disease are enough for the care of
the individual as a whole, or whether they are targeted
to the achievement of very specific quantitative goals,
which may or may not be accomplished, depending on
the socio-historical context in which the individual is
inserted.
From this perspective, it is necessary to strengthen the
role of primary health care in the assistance provided to
these individuals for the identification of vulnerabilities
and reduction of health inequities in order to ensure
that care actions will be carried out in a bidirectional
and reciprocal way. It will then be possible to see pa-
tients beyond the disease and encourage them to move
on with their life projects so that these patients can con-
tribute to the potential adherence and success of the
treatment. Moreover, these care actions should be
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reinforced by social incentives, especially at municipal
level, geographically responsible for the execution of dis-
ease action control.
It is important that health professionals and managers
recognize tuberculosis as a socially determined disease.
They should also try to understand the social context in
which the patient is inserted and the patient’s perception
on the factors connected to the disease, in such a way
that treatment adherence can be strengthened and cure
and loss-to-follow-up rates can be improved with the ac-
tive and critical participation of patients and the society.
Endnotes
1The responses were accurately translated into the
English language in the final phase of the writing manu-
script preparation.
2Coxcip-4 is a drug in pill form with fixed-dose com-
bination of rifampicin, isoniazid, pyrazinamide and eth-
ambutol. It is used in the acute phase of the disease (the
first 2 months of the antituberculosis treatment)4.
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